Anticoagulation Control in Different Ethnic Groups Receiving Vitamin K Antagonist for Stroke Prevention in Atrial Fibrillation
Vitamin K antagonist such as warfarin reduces the risk of stroke in atrial fibrillation (AF) patients. Since warfarin has a narrow therapeutic index, its administration needs to be regularly monitored to avoid any adverse clinical outcomes such as stroke and bleeding. The quality of anticoagulation...
Guardado en:
Autores principales: | Nur Azyyati Zawawi, Izzati Abdul Halim Zaki, Long Chiau Ming, Hui Poh Goh, Hanis Hanum Zulkifly |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/60a277a526ab4bbf9921204e0a6b5032 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Severe gastrointestinal bleeding in patients with atrial fibrillation receiving oral anticoagulants (based on REGistry of long-term AnTithrombotic TherApy – REGATTA)
por: Ekaterina S. Kropacheva, et al.
Publicado: (2021) -
Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies
por: Amin A
Publicado: (2013) -
ANTICOAGULATION CONTROL AMONG PATIENTS WITH ATRIAL FIBRILLATION
por: Amer Rauf, et al.
Publicado: (2020) -
Avances en la prevención de eventos tromboembólicos en pacientes con fibrilación auricular
por: Montagna M,Rodrigo, et al.
Publicado: (2007) -
Long-term effect of anticoagulation following left atrial appendage occlusion with the LARIAT device in patients with nonvalvular atrial fibrillation: impact on thromboembolism, bleeding and mortality. Real life data
por: Radosław Litwinowicz, et al.
Publicado: (2020)